Track the 窪田製薬ホールディングス株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 窪田製薬ホールディングス株式会社 has logged 63 reports. Market capitalisation: €9.3bn. The latest transaction was filed on 14 July 2026 (Holding update). Among the most active insiders: Barclays Bank PLC. All data is accessible without an account.
63
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,773 of 28,549 companies
11.6
score / 100
Value
19
Quality
4
FCF yld-6.1%
Earn yld-7.0%
EV/EBITDA·
ROE-51%
Gross mgn-22%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
